GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management. - Zuberbier, Torsten; Muraro, Antonella; Nurmatov, Ulugbek; Arasi, Stefania; Stevanovic, Katarina; Anagnostou, Aikaterini; Bonaguro, Roberta; Chinthrajah, Sharon; Lack, Gideon; Fiocchi, Alessandro; Le, Thuy‐My; Turner, Paul; et al. (Clinical & Translational Allergy, 2024)